Trial NCT02356458

View at ClinicalTrials.gov 
Org. Study IDs: SAKK 36/13
Secondary IDs: 2014-003893-17 SNCTP000001235

Last trial update was posted on 2022-03-11

MeSH Interventions

Bortezomib Ibrutinib

MeSH Conditions

Lymphoma Lymphoma, Mantle-Cell

Other Conditions

Mantle Cell Lymphoma

Stopping Reasons

SAKK Board decision of 14th November 2020 due to financial reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID